Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions - PubMed (original) (raw)

Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions

A Billich et al. J Virol. 1995 Apr.

Abstract

Cyclosporins, in particular the nonimmunosuppressive derivative SDZ NIM 811, exhibit potent anti-human immunodeficiency virus type 1 (HIV-1) activity in vitro. SDZ NIM 811 interferes at two stages of the viral replication cycle: (i) translocation of the preintegration complex to the nucleus and (ii) production of infectious virus particles. Immunosuppressive activity is not correlated with anti-HIV-1 activity of cyclosporins. However, binding to cyclophilin A, the major cellular receptor protein of cyclosporins, is a prerequisite for HIV inhibition: all structural changes of the cyclosporin A molecule leading to loss of affinity to cyclophilin abolished the antiviral effect. Cyclosporin derivatives did not interact directly with HIV-1 proteins; cyclophilin was the only detectable receptor protein for antivirally active cyclosporins. There is no evidence that inhibition of HIV occurs via a gain of function of cyclophilin in the presence of cyclosporins: the complex of cyclophilin A with SDZ NIM 811 does not bind to calcineurin or to any other viral or cellular proteins under conditions in which calcineurin binding to the cyclophilin A-cyclosporin A complex is easily detectable. Thus, the loss of function caused by binding of cyclosporins to cyclophilin seems to be sufficient for the anti-HIV effect. Cyclophilin A was demonstrated to bind to HIV-1 p24gag, and the formation of complexes was blocked by cyclosporins with 50% inhibitory concentrations of about 0.7 microM. HIV-2 and simian immunodeficiency virus are only weakly or not at all inhibited by cyclosporins. For gag-encoded proteins derived from HIV-1, HIV-2, or simian immunodeficiency virus particles, cyclophilin-binding capacity correlated with sensitivity of the viruses to inhibition by cyclosporins. Cyclophilin A also binds to HIV-1 proteins other than gag-encoded proteins, namely, p17gag, Nef, Vif, and gp120env; the biological significance of these interactions is questionable. We conclude that HIV-1 Gag-cyclophilin A interaction may be essential in HIV-1 replication, and interference with this interaction may be the molecular basis for the antiviral activity of cyclosporins.

PubMed Disclaimer

Similar articles

• The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811.
  Dorfman T, Göttlinger HG. Dorfman T, et al. J Virol. 1996 Sep;70(9):5751-7. doi: 10.1128/JVI.70.9.5751-5757.1996. J Virol. 1996. PMID: 8709190 Free PMC article.
• Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): interference with early and late events in HIV-1 replication.
  Steinkasserer A, Harrison R, Billich A, Hammerschmid F, Werner G, Wolff B, Peichl P, Palfi G, Schnitzel W, Mlynar E, et al. Steinkasserer A, et al. J Virol. 1995 Feb;69(2):814-24. doi: 10.1128/JVI.69.2.814-824.1995. J Virol. 1995. PMID: 7815548 Free PMC article.
• Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog.
  Rosenwirth B, Billich A, Datema R, Donatsch P, Hammerschmid F, Harrison R, Hiestand P, Jaksche H, Mayer P, Peichl P, et al. Rosenwirth B, et al. Antimicrob Agents Chemother. 1994 Aug;38(8):1763-72. doi: 10.1128/AAC.38.8.1763. Antimicrob Agents Chemother. 1994. PMID: 7527198 Free PMC article.
• Molecular mechanisms of immunosuppression by cyclosporins.
  Zenke G, Baumann G, Wenger R, Hiestand P, Quesniaux V, Andersen E, Schreier MH. Zenke G, et al. Ann N Y Acad Sci. 1993 Jun 23;685:330-5. doi: 10.1111/j.1749-6632.1993.tb35882.x. Ann N Y Acad Sci. 1993. PMID: 7689806 Review.
• Suppression of coronavirus replication by cyclophilin inhibitors.
  Tanaka Y, Sato Y, Sasaki T. Tanaka Y, et al. Viruses. 2013 May 22;5(5):1250-60. doi: 10.3390/v5051250. Viruses. 2013. PMID: 23698397 Free PMC article. Review.

Cited by

• The intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding.
  Solbak SM, Reksten TR, Wray V, Bruns K, Horvli O, Raae AJ, Henklein P, Henklein P, Röder R, Mitzner D, Schubert U, Fossen T. Solbak SM, et al. BMC Struct Biol. 2010 Oct 4;10:31. doi: 10.1186/1472-6807-10-31. BMC Struct Biol. 2010. PMID: 20920334 Free PMC article.
• Peptidyl prolyl cis-trans isomerase activity of cyclophilin A in functional homo-oligomeric receptor expression.
  Helekar SA, Patrick J. Helekar SA, et al. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5432-7. doi: 10.1073/pnas.94.10.5432. Proc Natl Acad Sci U S A. 1997. PMID: 9144255 Free PMC article.
• Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms.
  Gallay PA, Ptak RG, Bobardt MD, Dumont JM, Vuagniaux G, Rosenwirth B. Gallay PA, et al. Viruses. 2013 Mar 22;5(3):981-97. doi: 10.3390/v5030981. Viruses. 2013. PMID: 23524389 Free PMC article.
• Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions.
  Dorfman T, Weimann A, Borsetti A, Walsh CT, Göttlinger HG. Dorfman T, et al. J Virol. 1997 Sep;71(9):7110-3. doi: 10.1128/JVI.71.9.7110-7113.1997. J Virol. 1997. PMID: 9261445 Free PMC article.
• N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles.
  Gross I, Hohenberg H, Huckhagel C, Kräusslich HG. Gross I, et al. J Virol. 1998 Jun;72(6):4798-810. doi: 10.1128/JVI.72.6.4798-4810.1998. J Virol. 1998. PMID: 9573245 Free PMC article.

References

1. 1. Nature. 1981 Dec 24;294(5843):770-1 - PubMed
2. 1. Virology. 1989 Nov;173(1):258-67 - PubMed
3. 1. Science. 1984 May 4;224(4648):497-500 - PubMed
4. 1. Science. 1984 Nov 2;226(4674):544-7 - PubMed
5. 1. Biomed Biochim Acta. 1984;43(10):1101-11 - PubMed

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database